Home > Research > Publications & Outputs > Introduction

Electronic data

  • Introduction

    Rights statement: This article is (c) Emerald Group Publishing and permission has been granted for this version to appear here. Emerald does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Emerald Group Publishing Limited.

    Accepted author manuscript, 232 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Introduction: cultivation, medication, activism and cannabis policy

Research output: Contribution to Journal/MagazineEditorial

Published

Standard

Introduction: cultivation, medication, activism and cannabis policy. / Bone, Melissa; Potter, Gary Richard; Klein, Axel.
In: Drugs and Alcohol Today, Vol. 18, No. 2, 04.06.2018, p. 73-79.

Research output: Contribution to Journal/MagazineEditorial

Harvard

Bone, M, Potter, GR & Klein, A 2018, 'Introduction: cultivation, medication, activism and cannabis policy', Drugs and Alcohol Today, vol. 18, no. 2, pp. 73-79. https://doi.org/10.1108/DAT-03-2018-0014

APA

Vancouver

Bone M, Potter GR, Klein A. Introduction: cultivation, medication, activism and cannabis policy. Drugs and Alcohol Today. 2018 Jun 4;18(2):73-79. Epub 2018 May 9. doi: 10.1108/DAT-03-2018-0014

Author

Bone, Melissa ; Potter, Gary Richard ; Klein, Axel. / Introduction : cultivation, medication, activism and cannabis policy. In: Drugs and Alcohol Today. 2018 ; Vol. 18, No. 2. pp. 73-79.

Bibtex

@article{12d931a125bc429ebd5866196f6f7ec9,
title = "Introduction: cultivation, medication, activism and cannabis policy",
abstract = "On Friday 23rd February 2018 the medical cannabis bill introduced by UK Member of Parliament Paul Flynn went in for its second reading in the House of Commons. To the disappointment of several hundred activists assembled on the patch of green on Parliament Square in the freezing cold it never got to a vote, as the discussion on the preceding motion, Overseas Electors, dragged on.The event captured many of the issues transforming the field of drug policy, at least as related to cannabis. A large number of demonstrators were middle aged, a few had rolled up in wheel chairs, and the police were keeping a respectful distance. Cannabis use in the UK, as in many other countries, has come of age, itsrespectability confirmed by the rising flow of scientific evidence of its therapeuticbenefits. Politics, however, is out of step with scientific advances and changing social mores, held back by the counter weight of vested interests, the arrogance of political elites, and sheer inertia. Cannabis, whether for medical or non-medical use, remains illegal in the UK3, and most other countries, even as a growing number of jurisdictions change policy.",
keywords = "Social movements, Cannabis activism, Cannabis cultivation, Cannabis legalisation, Medical cannabis, Patient{\textquoteright}s voice",
author = "Melissa Bone and Potter, {Gary Richard} and Axel Klein",
note = "This article is (c) Emerald Group Publishing and permission has been granted for this version to appear here. Emerald does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Emerald Group Publishing Limited.",
year = "2018",
month = jun,
day = "4",
doi = "10.1108/DAT-03-2018-0014",
language = "English",
volume = "18",
pages = "73--79",
journal = "Drugs and Alcohol Today",
issn = "1745-9265",
publisher = "Emerald Group Publishing Ltd.",
number = "2",

}

RIS

TY - JOUR

T1 - Introduction

T2 - cultivation, medication, activism and cannabis policy

AU - Bone, Melissa

AU - Potter, Gary Richard

AU - Klein, Axel

N1 - This article is (c) Emerald Group Publishing and permission has been granted for this version to appear here. Emerald does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission from Emerald Group Publishing Limited.

PY - 2018/6/4

Y1 - 2018/6/4

N2 - On Friday 23rd February 2018 the medical cannabis bill introduced by UK Member of Parliament Paul Flynn went in for its second reading in the House of Commons. To the disappointment of several hundred activists assembled on the patch of green on Parliament Square in the freezing cold it never got to a vote, as the discussion on the preceding motion, Overseas Electors, dragged on.The event captured many of the issues transforming the field of drug policy, at least as related to cannabis. A large number of demonstrators were middle aged, a few had rolled up in wheel chairs, and the police were keeping a respectful distance. Cannabis use in the UK, as in many other countries, has come of age, itsrespectability confirmed by the rising flow of scientific evidence of its therapeuticbenefits. Politics, however, is out of step with scientific advances and changing social mores, held back by the counter weight of vested interests, the arrogance of political elites, and sheer inertia. Cannabis, whether for medical or non-medical use, remains illegal in the UK3, and most other countries, even as a growing number of jurisdictions change policy.

AB - On Friday 23rd February 2018 the medical cannabis bill introduced by UK Member of Parliament Paul Flynn went in for its second reading in the House of Commons. To the disappointment of several hundred activists assembled on the patch of green on Parliament Square in the freezing cold it never got to a vote, as the discussion on the preceding motion, Overseas Electors, dragged on.The event captured many of the issues transforming the field of drug policy, at least as related to cannabis. A large number of demonstrators were middle aged, a few had rolled up in wheel chairs, and the police were keeping a respectful distance. Cannabis use in the UK, as in many other countries, has come of age, itsrespectability confirmed by the rising flow of scientific evidence of its therapeuticbenefits. Politics, however, is out of step with scientific advances and changing social mores, held back by the counter weight of vested interests, the arrogance of political elites, and sheer inertia. Cannabis, whether for medical or non-medical use, remains illegal in the UK3, and most other countries, even as a growing number of jurisdictions change policy.

KW - Social movements

KW - Cannabis activism

KW - Cannabis cultivation

KW - Cannabis legalisation

KW - Medical cannabis

KW - Patient’s voice

U2 - 10.1108/DAT-03-2018-0014

DO - 10.1108/DAT-03-2018-0014

M3 - Editorial

VL - 18

SP - 73

EP - 79

JO - Drugs and Alcohol Today

JF - Drugs and Alcohol Today

SN - 1745-9265

IS - 2

ER -